Pharmaceutical care for patients with ischemic stroke: improving the patients quality of life View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-10

AUTHORS

Carina Hohmann, Jürgen M. Klotz, Roland Radziwill, Andreas H. Jacobs, Thomas Kissel

ABSTRACT

OBJECTIVES: To improve patients health-related quality of life (HQL) after transient ischemic attack (TIA) or ischemic stroke; to guarantee an effective secondary prevention; to increase the patient's satisfaction with recommendations regarding their medication by pharmacists. SETTING: Stroke Unit, neurological ward at the Klinikum Fulda, rehabilitation hospitals and community-based pharmacies in the region of Fulda, Germany. METHOD: Patients with TIA or ischemic stroke were included. The patients were assigned to an intervention group (IG) or a control group (CG). The individual assignment of patients to IG or CG was based on the type of the local pharmacy to which patients belong. Community-based pharmacies either delivered standard care (CG) or provided additional intensified pharmaceutical care (PC; IG). Pharmacies delivering PC belong to a pre-existing "Quality Assurance Working Group" (QAWG). To evaluate the patient's HQL, the Short Form-36 (SF-36) was used at study entry in hospital and at 12 months. The secondary prevention was documented at study entry in hospital and at 12 months. The patients' satisfaction was measured by a questionnaire at the end of the study. MAIN OUTCOME MEASURES: Patients' HQL; secondary prevention; patients' satisfaction with recommendations of the pharmacists with regards to their medication. RESULTS: Out of 1316 patients screened for participation in this study, 255 were recruited with 90/255 patients assigned to the IG and 165/255 patients assigned to the CG. During the study, the HQL of the patients in the IG did not change significantly. A significant decrease in the HQL was observed for the CG in 7/8 subscales and in both summary measures of the SF-36. After 12 months, 85.3% of the patients in the IG and 86.3% of the patients in the CG were treated with antiplatelet drugs or oral anticoagulants in accordance to treatment guidelines. Patients in the IG were significantly more satisfied with the individualized recommendations of the pharmacists than patients in the CG. CONCLUSION: Our findings indicate that an intensified PC of patients after ischemic stroke by dedicated pharmacists may have a positive impact on HQL and patients' satisfaction. PC in this study had no impact on adherence to secondary prevention medication. More... »

PAGES

550-558

References to SciGraph publications

  • 2001-02. "No thank you": Why elderly patients declined to participate in a research study in INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s11096-009-9315-y

    DOI

    http://dx.doi.org/10.1007/s11096-009-9315-y

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1042616461

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/19633917


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Public Health and Health Services", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Brain Ischemia", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Community Pharmacy Services", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Follow-Up Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pharmaceutical Services", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pharmacists", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Quality of Life", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Stroke", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Klinikum Fulda", 
              "id": "https://www.grid.ac/institutes/grid.419818.d", 
              "name": [
                "Department of Pharmacy and Patient Counselling, Klinikum Fulda gAG, Pacelliallee 4, 36043, Fulda, Germany", 
                "Department of Neurology, Klinikum Fulda gAG, Pacelliallee 4, 36043, Fulda, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hohmann", 
            "givenName": "Carina", 
            "id": "sg:person.01342021560.36", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342021560.36"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Klinikum Fulda", 
              "id": "https://www.grid.ac/institutes/grid.419818.d", 
              "name": [
                "Department of Neurology, Klinikum Fulda gAG, Pacelliallee 4, 36043, Fulda, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Klotz", 
            "givenName": "J\u00fcrgen M.", 
            "id": "sg:person.01136561502.77", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136561502.77"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Klinikum Fulda", 
              "id": "https://www.grid.ac/institutes/grid.419818.d", 
              "name": [
                "Department of Pharmacy and Patient Counselling, Klinikum Fulda gAG, Pacelliallee 4, 36043, Fulda, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Radziwill", 
            "givenName": "Roland", 
            "id": "sg:person.01367236502.81", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367236502.81"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Klinikum Fulda", 
              "id": "https://www.grid.ac/institutes/grid.419818.d", 
              "name": [
                "Department of Neurology, Klinikum Fulda gAG, Pacelliallee 4, 36043, Fulda, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jacobs", 
            "givenName": "Andreas H.", 
            "id": "sg:person.01176345110.57", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176345110.57"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Philipp University of Marburg", 
              "id": "https://www.grid.ac/institutes/grid.10253.35", 
              "name": [
                "Department of Pharmaceutical Technology and Biopharmacy, Philipps University of Marburg, Ketzerbach 63, 35037, Marburg, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kissel", 
            "givenName": "Thomas", 
            "id": "sg:person.01327274201.86", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327274201.86"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1023/a:1011276924820", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009618239", 
              "https://doi.org/10.1023/a:1011276924820"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1191/0269215505cr900oa", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013629998"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1191/0269215505cr900oa", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013629998"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1345/aph.1g180", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013931790"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1345/aph.1g180", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013931790"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/00912700122010438", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015057377"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejm199603283341306", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015518674"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1345/aph.1g458", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022278660"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1345/aph.1g458", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022278660"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.str.29.12.2501", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034569741"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.str.0000116869.64771.5a", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035109188"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.str.0000116869.64771.5a", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035109188"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1378/chest.114.5_supplement.683s", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038243558"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.str.0000015030.59594.b3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041410580"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/hs1101.098524", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046391631"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1136/bmj.324.7329.71", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046678775"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0140-6736(90)90878-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047398664"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0140-6736(90)90878-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047398664"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s1086-5802(16)31255-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051183302"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.str.27.10.1812", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1063341786"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.str.27.9.1479", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1063342063"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1074829440", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1076376836", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1078650598", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/ajhp/47.3.533", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1078650598"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/ajhp/47.3.533", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1078650598"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/ajhp/47.3.533", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1078650598"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2009-10", 
        "datePublishedReg": "2009-10-01", 
        "description": "OBJECTIVES: To improve patients health-related quality of life (HQL) after transient ischemic attack (TIA) or ischemic stroke; to guarantee an effective secondary prevention; to increase the patient's satisfaction with recommendations regarding their medication by pharmacists.\nSETTING: Stroke Unit, neurological ward at the Klinikum Fulda, rehabilitation hospitals and community-based pharmacies in the region of Fulda, Germany.\nMETHOD: Patients with TIA or ischemic stroke were included. The patients were assigned to an intervention group (IG) or a control group (CG). The individual assignment of patients to IG or CG was based on the type of the local pharmacy to which patients belong. Community-based pharmacies either delivered standard care (CG) or provided additional intensified pharmaceutical care (PC; IG). Pharmacies delivering PC belong to a pre-existing \"Quality Assurance Working Group\" (QAWG). To evaluate the patient's HQL, the Short Form-36 (SF-36) was used at study entry in hospital and at 12 months. The secondary prevention was documented at study entry in hospital and at 12 months. The patients' satisfaction was measured by a questionnaire at the end of the study.\nMAIN OUTCOME MEASURES: Patients' HQL; secondary prevention; patients' satisfaction with recommendations of the pharmacists with regards to their medication.\nRESULTS: Out of 1316 patients screened for participation in this study, 255 were recruited with 90/255 patients assigned to the IG and 165/255 patients assigned to the CG. During the study, the HQL of the patients in the IG did not change significantly. A significant decrease in the HQL was observed for the CG in 7/8 subscales and in both summary measures of the SF-36. After 12 months, 85.3% of the patients in the IG and 86.3% of the patients in the CG were treated with antiplatelet drugs or oral anticoagulants in accordance to treatment guidelines. Patients in the IG were significantly more satisfied with the individualized recommendations of the pharmacists than patients in the CG.\nCONCLUSION: Our findings indicate that an intensified PC of patients after ischemic stroke by dedicated pharmacists may have a positive impact on HQL and patients' satisfaction. PC in this study had no impact on adherence to secondary prevention medication.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1007/s11096-009-9315-y", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1044817", 
            "issn": [
              "2210-7703", 
              "2210-7711"
            ], 
            "name": "International Journal of Clinical Pharmacy", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "5", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "31"
          }
        ], 
        "name": "Pharmaceutical care for patients with ischemic stroke: improving the patients quality of life", 
        "pagination": "550-558", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "cb0003b811eeca14678b6636ddb4e823542217eb748eca2226c73ca1a7eb9404"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "19633917"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "9307352"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s11096-009-9315-y"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1042616461"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s11096-009-9315-y", 
          "https://app.dimensions.ai/details/publication/pub.1042616461"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T10:37", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113676_00000001.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://link.springer.com/10.1007%2Fs11096-009-9315-y"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11096-009-9315-y'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11096-009-9315-y'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11096-009-9315-y'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11096-009-9315-y'


     

    This table displays all metadata directly associated to this object as RDF triples.

    207 TRIPLES      21 PREDICATES      61 URIs      33 LITERALS      21 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s11096-009-9315-y schema:about N0313ddc30eb146b6ba6fadeaa0cb0c3e
    2 N3312577ec0f2423fb2f9e3f389d88bec
    3 N3ae714bc269a49a9be06be73084c4cf2
    4 N4f6dd16ab72142e28506b6af3a587dc4
    5 N50827aabcf3740d094e0389ab82d8653
    6 N53aedf86f6e840bba99ef66cafb8a2ec
    7 N67ed2e951d714c12a93157d0c94578b2
    8 N9d1c23d211574025b0be3e91224f7963
    9 Na4eb2a9cc7e143b18f139261838e7a39
    10 Nb175013c11ef4a8891fd62cbf9f60689
    11 Nd0250890eed84d4da6f24ea8af8c8f0e
    12 Ned7cf752715b4049ba7571e959c10be3
    13 anzsrc-for:11
    14 anzsrc-for:1117
    15 schema:author Naa877ef9a28443df8ec70771ee5267c3
    16 schema:citation sg:pub.10.1023/a:1011276924820
    17 https://app.dimensions.ai/details/publication/pub.1074829440
    18 https://app.dimensions.ai/details/publication/pub.1076376836
    19 https://app.dimensions.ai/details/publication/pub.1078650598
    20 https://doi.org/10.1016/0140-6736(90)90878-9
    21 https://doi.org/10.1016/s1086-5802(16)31255-4
    22 https://doi.org/10.1056/nejm199603283341306
    23 https://doi.org/10.1093/ajhp/47.3.533
    24 https://doi.org/10.1136/bmj.324.7329.71
    25 https://doi.org/10.1161/01.str.0000015030.59594.b3
    26 https://doi.org/10.1161/01.str.0000116869.64771.5a
    27 https://doi.org/10.1161/01.str.27.10.1812
    28 https://doi.org/10.1161/01.str.27.9.1479
    29 https://doi.org/10.1161/01.str.29.12.2501
    30 https://doi.org/10.1161/hs1101.098524
    31 https://doi.org/10.1177/00912700122010438
    32 https://doi.org/10.1191/0269215505cr900oa
    33 https://doi.org/10.1345/aph.1g180
    34 https://doi.org/10.1345/aph.1g458
    35 https://doi.org/10.1378/chest.114.5_supplement.683s
    36 schema:datePublished 2009-10
    37 schema:datePublishedReg 2009-10-01
    38 schema:description OBJECTIVES: To improve patients health-related quality of life (HQL) after transient ischemic attack (TIA) or ischemic stroke; to guarantee an effective secondary prevention; to increase the patient's satisfaction with recommendations regarding their medication by pharmacists. SETTING: Stroke Unit, neurological ward at the Klinikum Fulda, rehabilitation hospitals and community-based pharmacies in the region of Fulda, Germany. METHOD: Patients with TIA or ischemic stroke were included. The patients were assigned to an intervention group (IG) or a control group (CG). The individual assignment of patients to IG or CG was based on the type of the local pharmacy to which patients belong. Community-based pharmacies either delivered standard care (CG) or provided additional intensified pharmaceutical care (PC; IG). Pharmacies delivering PC belong to a pre-existing "Quality Assurance Working Group" (QAWG). To evaluate the patient's HQL, the Short Form-36 (SF-36) was used at study entry in hospital and at 12 months. The secondary prevention was documented at study entry in hospital and at 12 months. The patients' satisfaction was measured by a questionnaire at the end of the study. MAIN OUTCOME MEASURES: Patients' HQL; secondary prevention; patients' satisfaction with recommendations of the pharmacists with regards to their medication. RESULTS: Out of 1316 patients screened for participation in this study, 255 were recruited with 90/255 patients assigned to the IG and 165/255 patients assigned to the CG. During the study, the HQL of the patients in the IG did not change significantly. A significant decrease in the HQL was observed for the CG in 7/8 subscales and in both summary measures of the SF-36. After 12 months, 85.3% of the patients in the IG and 86.3% of the patients in the CG were treated with antiplatelet drugs or oral anticoagulants in accordance to treatment guidelines. Patients in the IG were significantly more satisfied with the individualized recommendations of the pharmacists than patients in the CG. CONCLUSION: Our findings indicate that an intensified PC of patients after ischemic stroke by dedicated pharmacists may have a positive impact on HQL and patients' satisfaction. PC in this study had no impact on adherence to secondary prevention medication.
    39 schema:genre research_article
    40 schema:inLanguage en
    41 schema:isAccessibleForFree false
    42 schema:isPartOf N102e381fe66b4f2f9353d05f8ac663ac
    43 N5bc40434df304df4bd6e32a8e17beedc
    44 sg:journal.1044817
    45 schema:name Pharmaceutical care for patients with ischemic stroke: improving the patients quality of life
    46 schema:pagination 550-558
    47 schema:productId N488df6c5820b4632a427f4196f6c1f11
    48 N8be7d51b50634d878941ea14f504ed19
    49 Nb86a2978f01d4676bed80731fa4e3e66
    50 Nc0a171923b1447678e9ab48cdd0c106b
    51 Nf24967def7b5414c8860ebfca1432573
    52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042616461
    53 https://doi.org/10.1007/s11096-009-9315-y
    54 schema:sdDatePublished 2019-04-11T10:37
    55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    56 schema:sdPublisher N2abbdb18cbc54072864de48a0e1d6602
    57 schema:url https://link.springer.com/10.1007%2Fs11096-009-9315-y
    58 sgo:license sg:explorer/license/
    59 sgo:sdDataset articles
    60 rdf:type schema:ScholarlyArticle
    61 N0313ddc30eb146b6ba6fadeaa0cb0c3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    62 schema:name Pharmacists
    63 rdf:type schema:DefinedTerm
    64 N102e381fe66b4f2f9353d05f8ac663ac schema:issueNumber 5
    65 rdf:type schema:PublicationIssue
    66 N2abbdb18cbc54072864de48a0e1d6602 schema:name Springer Nature - SN SciGraph project
    67 rdf:type schema:Organization
    68 N3312577ec0f2423fb2f9e3f389d88bec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    69 schema:name Female
    70 rdf:type schema:DefinedTerm
    71 N3a296ca02fdd4e05849bde913a7de523 rdf:first sg:person.01176345110.57
    72 rdf:rest N667010606fb14405a6be65aefc9cf602
    73 N3ae714bc269a49a9be06be73084c4cf2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    74 schema:name Pharmaceutical Services
    75 rdf:type schema:DefinedTerm
    76 N488df6c5820b4632a427f4196f6c1f11 schema:name readcube_id
    77 schema:value cb0003b811eeca14678b6636ddb4e823542217eb748eca2226c73ca1a7eb9404
    78 rdf:type schema:PropertyValue
    79 N4f6dd16ab72142e28506b6af3a587dc4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    80 schema:name Aged
    81 rdf:type schema:DefinedTerm
    82 N506e377ea9c746dba42e9f3c6e0843f5 rdf:first sg:person.01136561502.77
    83 rdf:rest Nc17071c074eb4461b3eb6bc4dee4fea6
    84 N50827aabcf3740d094e0389ab82d8653 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    85 schema:name Quality of Life
    86 rdf:type schema:DefinedTerm
    87 N53aedf86f6e840bba99ef66cafb8a2ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    88 schema:name Stroke
    89 rdf:type schema:DefinedTerm
    90 N5bc40434df304df4bd6e32a8e17beedc schema:volumeNumber 31
    91 rdf:type schema:PublicationVolume
    92 N667010606fb14405a6be65aefc9cf602 rdf:first sg:person.01327274201.86
    93 rdf:rest rdf:nil
    94 N67ed2e951d714c12a93157d0c94578b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    95 schema:name Community Pharmacy Services
    96 rdf:type schema:DefinedTerm
    97 N8be7d51b50634d878941ea14f504ed19 schema:name pubmed_id
    98 schema:value 19633917
    99 rdf:type schema:PropertyValue
    100 N9d1c23d211574025b0be3e91224f7963 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    101 schema:name Brain Ischemia
    102 rdf:type schema:DefinedTerm
    103 Na4eb2a9cc7e143b18f139261838e7a39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    104 schema:name Middle Aged
    105 rdf:type schema:DefinedTerm
    106 Naa877ef9a28443df8ec70771ee5267c3 rdf:first sg:person.01342021560.36
    107 rdf:rest N506e377ea9c746dba42e9f3c6e0843f5
    108 Nb175013c11ef4a8891fd62cbf9f60689 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    109 schema:name Follow-Up Studies
    110 rdf:type schema:DefinedTerm
    111 Nb86a2978f01d4676bed80731fa4e3e66 schema:name nlm_unique_id
    112 schema:value 9307352
    113 rdf:type schema:PropertyValue
    114 Nc0a171923b1447678e9ab48cdd0c106b schema:name dimensions_id
    115 schema:value pub.1042616461
    116 rdf:type schema:PropertyValue
    117 Nc17071c074eb4461b3eb6bc4dee4fea6 rdf:first sg:person.01367236502.81
    118 rdf:rest N3a296ca02fdd4e05849bde913a7de523
    119 Nd0250890eed84d4da6f24ea8af8c8f0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    120 schema:name Humans
    121 rdf:type schema:DefinedTerm
    122 Ned7cf752715b4049ba7571e959c10be3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Male
    124 rdf:type schema:DefinedTerm
    125 Nf24967def7b5414c8860ebfca1432573 schema:name doi
    126 schema:value 10.1007/s11096-009-9315-y
    127 rdf:type schema:PropertyValue
    128 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    129 schema:name Medical and Health Sciences
    130 rdf:type schema:DefinedTerm
    131 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
    132 schema:name Public Health and Health Services
    133 rdf:type schema:DefinedTerm
    134 sg:journal.1044817 schema:issn 2210-7703
    135 2210-7711
    136 schema:name International Journal of Clinical Pharmacy
    137 rdf:type schema:Periodical
    138 sg:person.01136561502.77 schema:affiliation https://www.grid.ac/institutes/grid.419818.d
    139 schema:familyName Klotz
    140 schema:givenName Jürgen M.
    141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136561502.77
    142 rdf:type schema:Person
    143 sg:person.01176345110.57 schema:affiliation https://www.grid.ac/institutes/grid.419818.d
    144 schema:familyName Jacobs
    145 schema:givenName Andreas H.
    146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176345110.57
    147 rdf:type schema:Person
    148 sg:person.01327274201.86 schema:affiliation https://www.grid.ac/institutes/grid.10253.35
    149 schema:familyName Kissel
    150 schema:givenName Thomas
    151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327274201.86
    152 rdf:type schema:Person
    153 sg:person.01342021560.36 schema:affiliation https://www.grid.ac/institutes/grid.419818.d
    154 schema:familyName Hohmann
    155 schema:givenName Carina
    156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342021560.36
    157 rdf:type schema:Person
    158 sg:person.01367236502.81 schema:affiliation https://www.grid.ac/institutes/grid.419818.d
    159 schema:familyName Radziwill
    160 schema:givenName Roland
    161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367236502.81
    162 rdf:type schema:Person
    163 sg:pub.10.1023/a:1011276924820 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009618239
    164 https://doi.org/10.1023/a:1011276924820
    165 rdf:type schema:CreativeWork
    166 https://app.dimensions.ai/details/publication/pub.1074829440 schema:CreativeWork
    167 https://app.dimensions.ai/details/publication/pub.1076376836 schema:CreativeWork
    168 https://app.dimensions.ai/details/publication/pub.1078650598 schema:CreativeWork
    169 https://doi.org/10.1016/0140-6736(90)90878-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047398664
    170 rdf:type schema:CreativeWork
    171 https://doi.org/10.1016/s1086-5802(16)31255-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051183302
    172 rdf:type schema:CreativeWork
    173 https://doi.org/10.1056/nejm199603283341306 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015518674
    174 rdf:type schema:CreativeWork
    175 https://doi.org/10.1093/ajhp/47.3.533 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078650598
    176 rdf:type schema:CreativeWork
    177 https://doi.org/10.1136/bmj.324.7329.71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046678775
    178 rdf:type schema:CreativeWork
    179 https://doi.org/10.1161/01.str.0000015030.59594.b3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041410580
    180 rdf:type schema:CreativeWork
    181 https://doi.org/10.1161/01.str.0000116869.64771.5a schema:sameAs https://app.dimensions.ai/details/publication/pub.1035109188
    182 rdf:type schema:CreativeWork
    183 https://doi.org/10.1161/01.str.27.10.1812 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063341786
    184 rdf:type schema:CreativeWork
    185 https://doi.org/10.1161/01.str.27.9.1479 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063342063
    186 rdf:type schema:CreativeWork
    187 https://doi.org/10.1161/01.str.29.12.2501 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034569741
    188 rdf:type schema:CreativeWork
    189 https://doi.org/10.1161/hs1101.098524 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046391631
    190 rdf:type schema:CreativeWork
    191 https://doi.org/10.1177/00912700122010438 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015057377
    192 rdf:type schema:CreativeWork
    193 https://doi.org/10.1191/0269215505cr900oa schema:sameAs https://app.dimensions.ai/details/publication/pub.1013629998
    194 rdf:type schema:CreativeWork
    195 https://doi.org/10.1345/aph.1g180 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013931790
    196 rdf:type schema:CreativeWork
    197 https://doi.org/10.1345/aph.1g458 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022278660
    198 rdf:type schema:CreativeWork
    199 https://doi.org/10.1378/chest.114.5_supplement.683s schema:sameAs https://app.dimensions.ai/details/publication/pub.1038243558
    200 rdf:type schema:CreativeWork
    201 https://www.grid.ac/institutes/grid.10253.35 schema:alternateName Philipp University of Marburg
    202 schema:name Department of Pharmaceutical Technology and Biopharmacy, Philipps University of Marburg, Ketzerbach 63, 35037, Marburg, Germany
    203 rdf:type schema:Organization
    204 https://www.grid.ac/institutes/grid.419818.d schema:alternateName Klinikum Fulda
    205 schema:name Department of Neurology, Klinikum Fulda gAG, Pacelliallee 4, 36043, Fulda, Germany
    206 Department of Pharmacy and Patient Counselling, Klinikum Fulda gAG, Pacelliallee 4, 36043, Fulda, Germany
    207 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...